Deletion of the C-terminus of ATR leads to DNA damage and an increase of aberrant cells.

Deletion of the C-terminus of ATR leads to DNA damage and an increase of aberrant cells.

<p>(A - B) Western analysis of whole cell extracts from mycATR and mycATRΔC-/- cells. Cells were left untreated (NT) or treated with 0.5 mM of Hydroxyurea (HU) for 20 hours (Chronic) or treated with 5 mM of Hydroxyurea (HU) for 5 hours (Acute), washed and resuspended in fresh media. The sample...

Description complète

Enregistré dans:

Détails bibliographiques
Auteur principal:	Gabriel L. A. da Silva (22676649) (author)
Autres auteurs:	Jeziel D. Damasceno (9073663) (author), Jennifer A. Black (14411790) (author), Craig Lapsley (6082646) (author), Richard McCulloch (12918) (author), Luiz R. O. Tosi (9073666) (author)
Publié:	2025
Sujets:	Biophysics Biochemistry Microbiology Cell Biology Genetics Molecular Biology Developmental Biology Science Policy Infectious Diseases Biological Sciences not elsewhere classified Physical Sciences not elsewhere classified major &# 8217 div >< p data reveals loss cells possess mechanisms remarkably plastic genome cas9 genome editing like family acts protein kinase ataxia atr depends upon delayed dna replication stranded dna accumulation leishmania major </ dna damage kinase dna damage genome stability leishmania </ dna metabolism dna injuries atr acts replication stress replication impediments work shows whose integrity terminal knockout smaller chromosomes protozoan parasite phosphatidylinositol 3 nuclear localisation mycatrδc -/-). mycatr ), master regulator larger chromosomes key role increased levels functional relevance eukaryotic response deletion results constantly challenged atr plays atr homolog atr ),
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Subcellular localisation of <i>L. major</i> ATR kinase depends on its C-terminus.
par: Gabriel L. A. da Silva (22676649)
Publié: (2025)

Deletion of the C-terminus of <i>L. major</i> ATR alters the protein’s abundance and sensitivity to replication stress.
par: Gabriel L. A. da Silva (22676649)
Publié: (2025)

ATR is necessary for genome stability and variability in <i>Leishmania major.</i>
par: Gabriel L. A. da Silva (22676649)
Publié: (2025)

ATR activity is important for DNA replication progression both from the early replicating locus in each chromosome and around putative replicative stress regions.
par: Gabriel L. A. da Silva (22676649)
Publié: (2025)

ATR is a determinant of the <i>L. major</i> DNA replication programme.
par: Gabriel L. A. da Silva (22676649)
Publié: (2025)

Replication stress leads to ssDNA accumulation, which affects the mechanisms influencing cell cycle progression in mycATRΔC-/- cells.
par: Gabriel L. A. da Silva (22676649)
Publié: (2025)

Text file of script for sequence analysis.
par: Gabriel L. A. da Silva (22676649)
Publié: (2025)

Table 1_Mechanistic study of TFE3 breakage in TFE3-rearranged renal cell carcinoma: the perspective of non-canonical DNA structures and their stability.docx
par: Xiaopo Zhang (402895)
Publié: (2025)

Figure 1 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors
par: Katrina M. Lappin (9340394)
Publié: (2025)

Figure 2 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors
par: Katrina M. Lappin (9340394)
Publié: (2025)

Figure 3 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors
par: Katrina M. Lappin (9340394)
Publié: (2025)

Figure 4 from Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors
par: Katrina M. Lappin (9340394)
Publié: (2025)

Supplementary Table S1 from G-Quadruplex Structures Are Key Modulators of Somatic Structural Variants in Cancers
par: Rongxin Zhang (15293341)
Publié: (2025)

Supplementary Table S2 from G-Quadruplex Structures Are Key Modulators of Somatic Structural Variants in Cancers
par: Rongxin Zhang (15293341)
Publié: (2025)

Supplementary Table S1 from Nucleophosmin Plays a Role in Repairing DNA Damage and Is a Target for Cancer Treatment
par: Konjeti R. Sekhar (15400345)
Publié: (2025)

Supplementary Table S2 from Nucleophosmin Plays a Role in Repairing DNA Damage and Is a Target for Cancer Treatment
par: Konjeti R. Sekhar (15400345)
Publié: (2025)

TableS1 from Enhancer Coamplification and Hijacking Promote Oncogene Expression in Liposarcoma
par: Tingting Liu (15386915)
Publié: (2025)

TableS2 from Enhancer Coamplification and Hijacking Promote Oncogene Expression in Liposarcoma
par: Tingting Liu (15386915)
Publié: (2025)

TableS3 from Enhancer Coamplification and Hijacking Promote Oncogene Expression in Liposarcoma
par: Tingting Liu (15386915)
Publié: (2025)

TableS4 from Enhancer Coamplification and Hijacking Promote Oncogene Expression in Liposarcoma
par: Tingting Liu (15386915)
Publié: (2025)

TableS5 from Enhancer Coamplification and Hijacking Promote Oncogene Expression in Liposarcoma
par: Tingting Liu (15386915)
Publié: (2025)

Supplementary Table S2 from Clinical Relevance of <i>BRCA1</i> Promoter Methylation Testing in Patients with Ovarian Cancer
par: Félix Blanc-Durand (15049400)
Publié: (2025)

Figure S1 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
par: Upendra Kumar Soni (15051683)
Publié: (2025)

Figure S2 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
par: Upendra Kumar Soni (15051683)
Publié: (2025)

Figure S3 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
par: Upendra Kumar Soni (15051683)
Publié: (2025)

Figure S4 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
par: Upendra Kumar Soni (15051683)
Publié: (2025)

Figure S5 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
par: Upendra Kumar Soni (15051683)
Publié: (2025)

Figure S6 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
par: Upendra Kumar Soni (15051683)
Publié: (2025)

Supplementary Data File S1 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
par: Upendra Kumar Soni (15051683)
Publié: (2025)

Table S1 from ENIGMA <i>CHEK2</i>gether Project: A Comprehensive Study Identifies Functionally Impaired <i>CHEK2</i> Germline Missense Variants Associated with Increased Breast Cancer Risk
par: Lenka Stolarova (16547259)
Publié: (2025)

Table S2 from ENIGMA <i>CHEK2</i>gether Project: A Comprehensive Study Identifies Functionally Impaired <i>CHEK2</i> Germline Missense Variants Associated with Increased Breast Cancer Risk
par: Lenka Stolarova (16547259)
Publié: (2025)

Table S3 from ENIGMA <i>CHEK2</i>gether Project: A Comprehensive Study Identifies Functionally Impaired <i>CHEK2</i> Germline Missense Variants Associated with Increased Breast Cancer Risk
par: Lenka Stolarova (16547259)
Publié: (2025)

Supplementary Results for GWAS meta-analysis of major depression (PGC MDD2025)
par: Mark James Adams (748366)
Publié: (2025)

Figure 1 from SMG8/SMG9 Heterodimer Loss Modulates SMG1 Kinase to Drive ATR Inhibitor Resistance
par: Marta J. Llorca-Cardenosa (14961612)
Publié: (2025)

Figure 2 from SMG8/SMG9 Heterodimer Loss Modulates SMG1 Kinase to Drive ATR Inhibitor Resistance
par: Marta J. Llorca-Cardenosa (14961612)
Publié: (2025)

Figure 3 from SMG8/SMG9 Heterodimer Loss Modulates SMG1 Kinase to Drive ATR Inhibitor Resistance
par: Marta J. Llorca-Cardenosa (14961612)
Publié: (2025)

Figure 4 from SMG8/SMG9 Heterodimer Loss Modulates SMG1 Kinase to Drive ATR Inhibitor Resistance
par: Marta J. Llorca-Cardenosa (14961612)
Publié: (2025)

Figure 5 from SMG8/SMG9 Heterodimer Loss Modulates SMG1 Kinase to Drive ATR Inhibitor Resistance
par: Marta J. Llorca-Cardenosa (14961612)
Publié: (2025)

Figure 1 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
par: Gonzalo Rodriguez-Berriguete (15056057)
Publié: (2025)

Figure 2 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
par: Gonzalo Rodriguez-Berriguete (15056057)
Publié: (2025)

Cannot write session to /tmp/vufind_sessions/sess_c87kbs6a8gj66tgled38s8afq5